COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges

In today’s world, the outbreak of the coronavirus disease 2019 (COVID-19) has spread throughout the world, causing severe acute respiratory syndrome (SARS) and several associated complications in various organs (heart, liver, kidney, and gastrointestinal tract), as well as significant multiple organ...

Full description

Bibliographic Details
Main Authors: Shimaa Abd El-Salam El-Sayed, Mohamed Abdo Rizk
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:BioMed
Subjects:
Online Access:https://www.mdpi.com/2673-8430/3/1/5
_version_ 1797613325192790016
author Shimaa Abd El-Salam El-Sayed
Mohamed Abdo Rizk
author_facet Shimaa Abd El-Salam El-Sayed
Mohamed Abdo Rizk
author_sort Shimaa Abd El-Salam El-Sayed
collection DOAJ
description In today’s world, the outbreak of the coronavirus disease 2019 (COVID-19) has spread throughout the world, causing severe acute respiratory syndrome (SARS) and several associated complications in various organs (heart, liver, kidney, and gastrointestinal tract), as well as significant multiple organ dysfunction, shock, and even death. In order to overcome the serious complications associated with this pandemic virus and to prevent SARS-CoV-2 entry into the host cell, it is necessary to repurpose currently available drugs with a broad medicinal application as soon as they become available. There are several therapeutics under investigation for improving the overall prognosis of COVID-19 patients, but none of them has demonstrated clinical efficacy to date, which is disappointing. It is in this pattern that <i>Nigella sativa</i> seeds manifest their extensive therapeutic effects, which have been reported to be particularly effective in the treatment of skin diseases, jaundice, and gastrointestinal problems. One important component of these seeds is thymoquinone (TQ), which has a wide range of beneficial properties, including antioxidant and anti-inflammatory properties, as well as antibacterial and parasitic properties, in addition to anticarcinogenic, antiallergic, and antiviral properties. This comprehensive review discussed the possibility of an emerging natural drug with a wide range of medical applications; the use of TQ to overcome the complications of COVID-19 infection; and the challenges that are impeding the commercialization of this promising phytochemical compound. TQ is recommended as a highly effective weapon in the fight against the novel coronavirus because of its dual antiviral action, in addition to its capacity to lessen the possibility of SARS-CoV-2 penetration into cells. However, future clinical trials are required to confirm the role of TQ in overcoming the complications of COVID-19 infection.
first_indexed 2024-03-11T06:54:17Z
format Article
id doaj.art-34056a8299e8452a83bdf380c7953077
institution Directory Open Access Journal
issn 2673-8430
language English
last_indexed 2024-03-11T06:54:17Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series BioMed
spelling doaj.art-34056a8299e8452a83bdf380c79530772023-11-17T09:43:22ZengMDPI AGBioMed2673-84302023-01-0131597610.3390/biomed3010005COVID-19 and Thymoquinone: Clinical Benefits, Cure, and ChallengesShimaa Abd El-Salam El-Sayed0Mohamed Abdo Rizk1Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, EgyptDepartment of Internal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, EgyptIn today’s world, the outbreak of the coronavirus disease 2019 (COVID-19) has spread throughout the world, causing severe acute respiratory syndrome (SARS) and several associated complications in various organs (heart, liver, kidney, and gastrointestinal tract), as well as significant multiple organ dysfunction, shock, and even death. In order to overcome the serious complications associated with this pandemic virus and to prevent SARS-CoV-2 entry into the host cell, it is necessary to repurpose currently available drugs with a broad medicinal application as soon as they become available. There are several therapeutics under investigation for improving the overall prognosis of COVID-19 patients, but none of them has demonstrated clinical efficacy to date, which is disappointing. It is in this pattern that <i>Nigella sativa</i> seeds manifest their extensive therapeutic effects, which have been reported to be particularly effective in the treatment of skin diseases, jaundice, and gastrointestinal problems. One important component of these seeds is thymoquinone (TQ), which has a wide range of beneficial properties, including antioxidant and anti-inflammatory properties, as well as antibacterial and parasitic properties, in addition to anticarcinogenic, antiallergic, and antiviral properties. This comprehensive review discussed the possibility of an emerging natural drug with a wide range of medical applications; the use of TQ to overcome the complications of COVID-19 infection; and the challenges that are impeding the commercialization of this promising phytochemical compound. TQ is recommended as a highly effective weapon in the fight against the novel coronavirus because of its dual antiviral action, in addition to its capacity to lessen the possibility of SARS-CoV-2 penetration into cells. However, future clinical trials are required to confirm the role of TQ in overcoming the complications of COVID-19 infection.https://www.mdpi.com/2673-8430/3/1/5COVID-19thymoquinonecomplications
spellingShingle Shimaa Abd El-Salam El-Sayed
Mohamed Abdo Rizk
COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
BioMed
COVID-19
thymoquinone
complications
title COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
title_full COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
title_fullStr COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
title_full_unstemmed COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
title_short COVID-19 and Thymoquinone: Clinical Benefits, Cure, and Challenges
title_sort covid 19 and thymoquinone clinical benefits cure and challenges
topic COVID-19
thymoquinone
complications
url https://www.mdpi.com/2673-8430/3/1/5
work_keys_str_mv AT shimaaabdelsalamelsayed covid19andthymoquinoneclinicalbenefitscureandchallenges
AT mohamedabdorizk covid19andthymoquinoneclinicalbenefitscureandchallenges